Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Open accessThe DOI matches its Crossref record; 273 of the 276 references it cites were found in a registry or an index.
Abstract
We describe a recently recognized disease entity, limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a stereotypical TDP-43 proteinopathy in older adults, with or without coexisting hippocampal sclerosis pathology. LATE-NC is a common TDP-43 proteinopathy, associated with an amnestic dementia syndrome that mimicked Alzheimer's-type dementia in retrospective autopsy studies. LATE is distinguished from frontotemporal lobar degeneration with TDP-43 pathology based on its epidemiology (LATE generally affects older subjects), and relatively restricted neuroanatomical distribution of TDP-43 proteinopathy. In community-based autopsy cohorts, ∼25% of brains had sufficient burden of LATE-NC to be associated with discernible cognitive impairment. Many subjects with LATE-NC have comorbid brain pathologies, often including amyloid-β plaques and tauopathy. Given that the 'oldest-old' are at greatest risk for LATE-NC, and subjects of advanced age constitute a rapidly growing demographic group in many countries, LATE has an expanding but under-recognized impact on public health. For these reasons, a working group was convened to develop diagnostic criteria for LATE, aiming both to stimulate research and to promote awareness of this pathway to dementia. We report consensus-based recommendations including guidelines for diagnosis and staging of LATE-NC. For routine autopsy workup of LATE-NC, an anatomically-based preliminary staging scheme is proposed with TDP-43 immunohistochemistry on tissue from three brain areas, reflecting a hierarchical pattern of brain involvement: amygdala, hippocampus, and middle frontal gyrus. LATE-NC appears to affect the medial temporal lobe structures preferentially, but other areas also are impacted. Neuroimaging studies demonstrated that subjects with LATE-NC also had atrophy in the medial temporal lobes, frontal cortex, and other brain regions. Genetic studies have thus far indicated five genes with risk alleles for LATE-NC: GRN, TMEM106B, ABCC9, KCNMB2, and APOE. The discovery of these genetic risk variants indicate that LATE shares pathogenetic mechanisms with both frontotemporal lobar degeneration and Alzheimer's disease, but also suggests disease-specific underlying mechanisms. Large gaps remain in our understanding of LATE. For advances in prevention, diagnosis, and treatment, there is an urgent need for research focused on LATE, including in vitro and animal models. An obstacle to clinical progress is lack of diagnostic tools, such as biofluid or neuroimaging biomarkers, for ante-mortem detection of LATE. Development of a disease biomarker would augment observational studies seeking to further define the risk factors, natural history, and clinical features of LATE, as well as eventual subject recruitment for targeted therapies in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Statistical analyses on data related to LATE from the Rush University community-based autopsy cohort depicting the results of pathway analyses. Data were analysed from research volunteers (total n = 1309) in two clinical‐pathological studies of ageing from Rush University as described previously (Power et al., 2018). In this sample, the mean age of death was 89.7 years [standard deviation (SD) 6.5 years, range 65–108 years]. These analyses incorporated age, density of amyloid-β neuritic amyloid plaques (to factor in ADNC), TDP-43 proteinopathy, hippocampal sclerosis pathology, and the endpoint of Alzheimer’s-type clinical dementia. The components of the pathway analyses most strongly associated with LATE-NC are shown in red. The numbers are path coefficients with standard error in parentheses (shown in purple). These numbers help to quantify the effects of individual pathways. For instance, the data are compatible with there being two pathways from TDP-43 proteinopathy to dementia, one direct pathway (TDP-43 proteinopathy→dementia) and the other indirect pathway that includes hippocampal sclerosis pathology (TDP-43 proteinopathy→hippocampal sclerosis→dementia): in the statistical model, the TDP-43 proteinopathy is independently associated with both hippocampal sclerosis pathology and clinical dementia status. Further, the data indicate that a subset of TDP-43 proteinopathy is ‘downstream’ of ADNC-type neuritic amyloid plaque pathology. In a practical sense, this means that brains with more neuritic amyloid plaques are more likely to have TDP-43 proteinopathy, with all other known factors being the same. Aβ = amyloid-β.](https://figures.cochat.ai/paper-figures/9bc83b3adf7f42d5a250b59d9652e7a1/limbic-predominant-age-related-tdp-43-encephalopathy-late-consensus-working-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A consensus group, for example, has described hippocampal sclerosis associated with TDP-43 proteinopathy, as limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia, usually found in people older than 80 years, progressing more slowly than Alzheimer's disease, detectable at post-mortem, often mimicking or comorbid with Alzheimer's disease.3”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“50–60% of Alzheimer’s-type dementia (dementia defined clinically as Alzheimer’s disease) is estimated to be attributable to these copathologies.40,42–45”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LATE is a recently described entity which affects older people and presents with an amnestic picture resembling Alzheimer's disease 178 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [178]
The cited source says what the claim attributes to it.
In the citing paper
“Limbic-predominant age-related TDP43 encephalopathy (LATE), defined approximately 3 years ago, is a condition in which typical TDP43 protein inclusions are present with or without coexisting hippocampal sclerosis.29”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“The predominant neuropathological change in LATE is TDP-43 proteinopathy, which is associated with a clinical presentation of amnestic dementia that can mimic Alzheimer's dementia.”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [20]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–273 of 273
Lin, W.-L., Castanedes-Casey, M., & Dickson, D. W. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181baacec · Cited by 61
Self-citationPhosphorylated TDP-43 Staging of Primary Age-Related Tauopathy
Zhang, X., Sun, B., Wang, X., Lu, H. J., Shao, F., Rozemüller, A. J. M., Liang, H., Liu, C., Chen, J., Huang, M., et al. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0300-0 · Cited by 60
Molecular Dissection of TDP-43 Proteinopathies
Hasegawa, M., Nonaka, T., Tsuji, H., Tamaoka, A., Yamashita, M., Kametani, F., Yoshida, M., Arai, T., & Akiyama, H. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9571-x · Cited by 58
Biomarkers for diseases with TDP-43 pathology
Steinacker, P., Barschke, P., & Otto, M. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.10.003 · Cited by 57
Pure hippocampal sclerosis: A rare cause of dementia mimicking Alzheimer’s disease
Jellinger, K. (2000) · Neurology · doi:10.1212/wnl.55.5.735-d · Cited by 57
Neuropathologic correlates of regional brain volumes in a community cohort of older adults
Kotrotsou, A., Schneider, J. A., Bennett, D. A., Leurgans, S. E., Dawe, R. J., Boyle, P. A., Golak, T., & Arfanakis, K. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.025 · Cited by 56
Self-citationMakkinejad, N., Schneider, J. A., Yu, J., Leurgans, S. E., Kotrotsou, A., Evia, A. M., Bennett, D. A., & Arfanakis, K. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.022 · Cited by 56
Self-citationHatanpaa, K. J., Raisanen, J. M., Herndon, E., Burns, D. K., Foong, C., Habib, A. A., & White, C. L. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/73.2.136 · Cited by 56
Sennik, S., Schweizer, T. A., Fischer, C. E., & Munoz, D. G. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160780 · Cited by 54
Hippocampal sclerosis in Alzheimer disease and other dementias
Attems, J., & Jellinger, K. A. (2006) · Neurology · doi:10.1212/01.wnl.0000200959.50898.26 · Cited by 53
Self-citationRauramaa, T., Pikkarainen, M., Englund, E., Ince, P. G., Jellinger, K., Paetau, A., & Alafuzoff, I. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318292492a · Cited by 52
Self-citationCykowski, M. D., Takei, H., Van Eldik, L. J., Schmitt, F. A., Jicha, G. A., Powell, S. Z., & Nelson, P. T. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw014 · Cited by 52
Self-citationA genome-wide association study of suicide attempts and suicidal ideation in U.S. military veterans
Kimbrel, N. A., Garrett, M. E., Dennis, M. F., Hauser, M. A., Ashley-Koch, A. E., & Beckham, J. C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.07.017 · Cited by 52
TDP-43 Pathology in the Population: Prevalence and Associations with Dementia and Age
Keage, H. A. D., Cohort, O. B. O. T. C. C. O. 7., Hunter, S., Matthews, F. E., Ince, P. G., Hodges, J., Hokkanen, S. R. K., Highley, J. R., Dening, T., & Brayne, C. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132351 · Cited by 49
Self-citation“End-Stage” Neurofibrillary Tangle Pathology in Preclinical Alzheimer's Disease: Fact or Fiction?
Abner, E. L., Kryscio, R. J., Schmitt, F. A., SantaCruz, K. S., Jicha, G. A., Lin, Y., Neltner, J. M., Smith, C. D., Van Eldik, L. J., & Nelson, P. T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101980 · Cited by 49
Self-citationEx vivo T2 relaxation: associations with age-related neuropathology and cognition
Dawe, R. J., Bennett, D. A., Schneider, J. A., Leurgans, S. E., Kotrotsou, A., Boyle, P. A., & Arfanakis, K. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.144 · Cited by 49
Self-citationZhou, X., Sun, L., Brady, O. A., Murphy, K. A., & Hu, F. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0412-1 · Cited by 49
Postmortem neurodegenerative markers and trajectories of decline in cognitive systems
Wilson, R. S., Yang, J., Yu, L., Leurgans, S. E., Capuano, A. W., Schneider, J. A., Bennett, D. A., & Boyle, P. A. (2019) · Neurology · doi:10.1212/wnl.0000000000006949 · Cited by 48
Self-citationHippocampal sclerosis, hippocampal neuron loss patterns and TDP‐43 in the aged population
Hokkanen, S. R. K., Hunter, S., Polvikoski, T. M., Keage, H. A. D., Minett, T., Matthews, F. E., Brayne, C., & MRC CFAS and CC75C Study Group (2018) · Brain Pathology · doi:10.1111/bpa.12556 · Cited by 47
Self-citationTMEM106B haplotypes have distinct gene expression patterns in aged brain
Ren, Y., van Blitterswijk, M., Allen, M., Carrasquillo, M. M., Reddy, J. S., Wang, X., Beach, T. G., Dickson, D. W., Ertekin-Taner, N., Asmann, Y. W., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0268-2 · Cited by 47
Self-citationNeuropathology of Hippocampal Sclerosis
Amador, C., & Dickson, D. W. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01253-5 · Cited by 45
Self-citationZarei, M. M., Song, M., Wilson, R. J., Cox, N., Colom, L. V., Knaus, H. G., Stefani, E., & Toro, L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.019 · Cited by 45
Ou, S. I., Chalmers, Z. R., Azada, M. C., Ross, J. S., Stephens, P. J., Ali, S. M., & Miller, V. A. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.03.014 · Cited by 43
In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies
Hanko, V., Apple, A. C., Alpert, K. I., Warren, K., Schneider, J. A., Arfanakis, K., Bennett, D. A., & Wang, L. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.013 · Cited by 43
Self-citationNascimento, C., Di Lorenzo Alho, A. T., Bazan Conceição Amaral, C., Leite, R. E. P., Nitrini, R., Jacob‐Filho, W., Pasqualucci, C. A., Hokkanen, S. R. K., Hunter, S., Keage, H., et al. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12430 · Cited by 41
Self-citationPopulation‐based analysis of pathological correlates of dementia in the oldest old
Tanskanen, M., Mäkelä, M., Notkola, I., Myllykangas, L., Rastas, S., Oinas, M., Lindsberg, P. J., Polvikoski, T., Tienari, P. J., & Paetau, A. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.389 · Cited by 40
Patterns of brain atrophy associated with episodic memory and semantic fluency decline in aging
Pelletier, A., Bernard, C., Dilharreguy, B., Helmer, C., Goff, M. L., Chanraud, S., Dartigues, J., Allard, M., Amieva, H., & Catheline, G. (2017) · Aging · doi:10.18632/aging.101186 · Cited by 39
Zarow, C., Wang, L., Chui, H. C., Weiner, M. W., & Csernansky, J. G. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/483972 · Cited by 38
Self-citationAlafuzoff, I. I., Pikkarainen, M., Neumann, M., Arzberger, T., Al‐Sarraj, S., Bódi, I., Bogdanović, N., Bugiani, O., Ferrer, I., Gelpí, E., et al. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1304-1 · Cited by 38
Self-citationHippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature
Ighodaro, E. T., Jicha, G. A., Schmitt, F. A., Neltner, J. H., Abner, E. L., Kryscio, R. J., Smith, C. D., Duplessis, T., Anderson, S., Patel, E., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000204 · Cited by 37
Self-citationNascimento, C., Suemoto, C. K., Rodriguez, R. D., Alho, A. T. D. L., Leite, R. P., Farfel, J. M., Pasqualucci, C. A. G., Jacob‐Filho, W., & Grinberg, L. T. (2016) · Brain Pathology · doi:10.1111/bpa.12296 · Cited by 36
Association Between Neuropathology and Brain Volume in The Framingham Heart Study
Kaur, B., Himali, J. J., Seshadri, S., Beiser, A. S., Au, R., McKee, A. C., Auerbach, S., Wolf, P. A., & DeCarli, C. S. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000032 · Cited by 36
Anterior Cingulate Cortex TDP-43 Pathology in Sporadic Amyotrophic Lateral Sclerosis
Braak, H., & Tredici, K. D. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx104 · Cited by 36
Hippocampal Sclerosis in the Oldest Old: A Finnish Population-Based Study
Kero, M., Raunio, A., Polvikoski, T. M., Tienari, P. J., Paetau, A. E., & Myllykangas, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171068 · Cited by 36
Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72
Murray, M. E., Bieniek, K. F., Banks Greenberg, M., DeJesus-Hernandez, M., Rutherford, N. J., van Blitterswijk, M., Niemantsverdriet, E., Ash, P. E., Gendron, T. F., Kouri, N., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1161-2 · Cited by 35
Self-citationNeuropathology of supercentenarians - four autopsy case studies
Takao, M., Hirose, N., Arai, Y., Mihara, B., & Mimura, M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0368-6 · Cited by 35
Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging
Initiative, A. D. N., Nelson, P. T., Katsumata, Y., Nho, K. T., Artiushin, S., Jicha, G. A., Wang, W., Abner, E. L., Saykin, A. J., Kukull, W. A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1641-2 · Cited by 35
Self-citationKatsumata, Y., Nelson, P. T., Ellingson, S. R., & Fardo, D. W. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.003 · Cited by 35
Self-citationNelson, P. T., Gal, Z. T., Wang, W., Niedowicz, D. M., Artiushin, S., Wycoff, S., Wei, A. L., Jicha, G. A., & Fardo, D. W. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.013 · Cited by 35
Self-citationUpdate on Hippocampal Sclerosis
Dutra, J. R., Cortes, E. P., & Vonsattel, J. P. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0592-7 · Cited by 34
Cykowski, M. D., Powell, S. Z., Schulz, P. E., Takei, H., Rivera, A. L., Jackson, R. E., Roman, G., Jicha, G. A., & Nelson, P. T. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0469-sa · Cited by 33
Self-citationResearch and Alzheimer's disease: an epidemiological perspective
Brayne, C. (1993) · Psychological Medicine · doi:10.1017/s003329170002835x · Cited by 32
Self-citationA novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma
Hsiao, S. J., Karajannis, M. A., Diolaiti, D., MANSUKHANI, M. M., Bender, J. G., Kung, A. L., & Garvin, J. H. (2016) · Molecular Case Studies · doi:10.1101/mcs.a001396 · Cited by 32
TDP-43 and Alzheimer’s Disease Pathologic Subtype in Non-Amnestic Alzheimer’s Disease Dementia
Sahoo, A., Bejanin, A., Murray, M. E., Tosakulwong, N., Weigand, S. D., Serie, A. M., Senjem, M. L., Machulda, M. M., Parisi, J. E., Boeve, B. F., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180169 · Cited by 32
Self-citationVerde, F., Tredici, K. D., & Braak, H. (2018) · ARCHIVES ITALIENNES DE BIOLOGIE · doi:10.12871/00039829201746 · Cited by 32
Abnormal Hippocampal Distribution of TDP-43 in Patients With-Late Onset Psychosis
Velakoulis, D., Walterfang, M., Mocellin, R., Pantelis, C., Dean, B., & McLean, C. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903001984 · Cited by 31
Nho, K., Initiative, A. D. N., Saykin, A. J., & Nelson, P. T. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160077 · Cited by 31
Self-citationRobinson, A. C., Davidson, Y. S., Horan, M. A., Pendleton, N., & Mann, D. M. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180171 · Cited by 31
Körtvelyessy, P., Heinze, H. J., Prudlo, J., & Bittner, D. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00504 · Cited by 31
Hippocampal sclerosis dementia: Expanding the phenotypes of frontotemporal dementias?
Lippa, C. F., & Dickson, D. W. (2004) · Neurology · doi:10.1212/01.wnl.0000136241.71716.72 · Cited by 28
Self-citationTAR-DNA binding protein-43 and alterations in the hippocampus
Rauramaa, T. H., Pikkarainen, M., Englund, E. M., Ince, P. G., Jellinger, K. A., Paetau, A. E., & Alafuzoff, I. I. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0574-5 · Cited by 28
Self-citationLack of association of the apoE4 allele with hippocampal sclerosis dementia
Troncoso, J. C., Kawas, C. H., Chang, C. K., Folstein, M. F., & Hedreen, J. C. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12331-4 · Cited by 26
Self-citationIttermann, T., Wittfeld, K., Nauck, M. A., Bülow, R., Hosten, N., Völzke, H., & Grabe, H. J. (2018) · Thyroid · doi:10.1089/thy.2017.0561 · Cited by 25
Popkirov, S., Ismail, F. S., Grönheit, W., Kapauer, M., Wellmer, J., & Bien, C. G. (2017) · Seizure · doi:10.1016/j.seizure.2017.07.006 · Cited by 23
Vassilaki, M. E., Aakre, J. A., Kremers, W. K., Mielke, M. M., Geda, Y. E., Alhurani, R. E., Dutt, T., Machulda, M. M., Knopman, D. S., Vemuri, P., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly149 · Cited by 23
Self-citationTDP-43 in Alzheimer’s disease is not associated with clinical FTLD or Parkinsonism
Jung, Y., Dickson, D. W., Murray, M. E., Whitwell, J. L., Knopman, D. S., Boeve, B. F., Jack, C. R., Parisi, J. E., Petersen, R. C., & Josephs, K. A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7352-5 · Cited by 22
Self-citationDefining SNAP by cross-sectional and longitudinal definitions of neurodegeneration
Wisse, L. E. M., Das, S. R., Davatzikos, C. A., Dickerson, B. C., Xie, S. X., Yushkevich, P. A., & Wolk, D. A. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.02.008 · Cited by 22
Risk factors of hippocampal sclerosis in the oldest old
Trieu, T., Sajjadi, S. A., Kawas, C. H., Nelson, P. T., & Corrada, M. M. (2018) · Neurology · doi:10.1212/wnl.0000000000006455 · Cited by 19
Self-citationThe TMEM106B locus and TDP-43 pathology in older persons without FTLD
Dickson, D. W., Rademakers, R., & Nicholson, A. M. (2015) · Neurology · doi:10.1212/01.wnl.0000472918.79256.a9 · Cited by 17
Self-citationProgressive Supranuclear Palsy in a family with TDP-43 pathology
Kertesz, A., Finger, E. C., Murrell, J. R., Chertkow, H. M., Ang, L. C., Baker, M., Ravenscroft, T. A., Rademakers, R., & Muñoz, D. G. (2014) · Neurocase · doi:10.1080/13554794.2013.878729 · Cited by 16
Self-citationTAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis
Vatsavayi, A. V. V., Kofler, J., DeMichele‐Sweet, M. A. A., Murray, P. S., López, O. L., & Sweet, R. A. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000246 · Cited by 16
Miki, Y., Mori, F., Seino, Y., Tanji, K., Yoshizawa, T., Kijima, H., Shoji, M., & Wakabayashi, K. (2018) · Neuropathology · doi:10.1111/neup.12484 · Cited by 16
Yu, M., Guo, L., Li, N., Henzel, K. S., Gu, H., Ran, X., Sun, W., Liu, S., Lu, Y., Ehninger, D., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00360 · Cited by 16
Aβ and the dementia syndrome: Simple versus complex perspectives
Hunter, S., Smailagic, N., & Brayne, C. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13025 · Cited by 15
Self-citationFardo, D. W., Katsumata, Y., Kauwe, J. S. K., Deming, Y. K., Harari, O., Cruchaga, C., & Nelson, P. T. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.01.025 · Cited by 14
Self-citationTan, R. H., Yang, Y., & Halliday, G. M. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12455 · Cited by 14
Self-citationMorphological imaging of the hippocampus in epilepsy
Isnard, J., & Bourdillon, P. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2014.12.002 · Cited by 13
Clinical Aspects of Hippocampal Sclerosis
Leverenz, J. B., & Lipton, A. M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01252-3 · Cited by 12
Disassociation of verbal learning and hippocampal volume in type 2 diabetes and major depression
Ajilore, O., Lamar, M., Medina, J., Watari, K. F., Elderkin‐Thompson, V., & Kumar, A. A. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4149 · Cited by 11
TDP‐43 in the olfactory bulb in Alzheimer's disease
Josephs, K. A., & Dickson, D. W. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12309 · Cited by 11
Self-citationPrevalence of hippocampal sclerosis in a clinicopathologically characterized cohort
Malek‐Ahmadi, M. H., Kahlon, V., Adler, C. H., Obradov, A., Thind, K., Shill, H. A., Sue, L. I., Caviness, J. N., Jacobson, S. A., & Sabbagh, M. N. (2013) · Clinical and Experimental Medical Sciences · doi:10.12988/cems.2013.13026 · Cited by 10
Clinicopathologic correlates in the oldest-old
Giannakopoulos, P., Bouras, C., & Hof, P. R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.015 · Cited by 9
The phenotype of bilateral hippocampal sclerosis and its management in “real life” clinical settings
Sen, A., Dugan, P. C., Perucca, P., Costello, D. J., Choi, H., Bazil, C. W., Radtke, R., Andrade, D. M., Depondt, C., Heavin, S. B., et al. (2018) · Epilepsia · doi:10.1111/epi.14436 · Cited by 8
Research works printed but not linked: 3
- Kuslansky, 2004, Hippocampal sclerosis: cognitive consequences and contribution to dementia, Neurology, 62, A128
- 2014, Dictionary of Epidemiology
- Thom, 2015, Epilepsy, 683
Cited by
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
Self-citationRetractedRevised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803
Self-citationBiomarkers for neurodegenerative diseases
Hansson, O. (2021) · Nature Medicine · doi:10.1038/s41591-021-01382-x · Cited by 1,159
Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00066-1 · Cited by 1,051
(2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-804766-8.00013-3 · Cited by 783
Metadata
- Authors
- Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., Coyle-Gilchrist, I. T. S., Chui, H. C., Fardo, D. W., Flanagan, M. E., Halliday, G., Hokkanen, S. R. K., Hunter, S., Jicha, G. A., Katsumata, Y., Kawas, C. H., Keene, C. D., Kovacs, G. G., Kukull, W. A., Levey, A. I., Makkinejad, N., Montine, T. J., Murayama, S., Murray, M. E., Nag, S., Rissman, R. A., Seeley, W. W., Sperling, R. A., White III, C. L., Yu, L., & Schneider, J. A.
- Affiliations
- University of Kentucky (US)
- Mayo Clinic in Florida (US)
- University of Pennsylvania (US)
- Mayo Clinic (US)
- Rush University Medical Center (US)
- Uppsala University (SE)
- Newcastle University (GB)
- University of Cambridge (GB)
- University of Southern California (US)
- University of Minnesota (US)
- The University of Sydney (AU)
- University of California, Irvine (US)
- University of Washington (US)
- Institute of Neurology Medical University of Vienna, Vienna, Austria
- Emory University (US)
- Illinois Institute of Technology (US)
- Stanford University (US)
- Tokyo Metropolitan Institute of Gerontology (JP)
- University of California San Diego (US)
- University of California, San Francisco (US)
- Harvard University (US)
- University of Texas Southwestern Medical Center, Dallas, TX, USA
- Corresponding author
- Nelson, Peter T
- ORCID
- Nelson, Peter T
- Dickson, Dennis W
- Trojanowski, John Q
- Jack, Clifford R
- Boyle, Patricia A
- Arfanakis, Konstantinos
- Rademakers, Rosa
- Alafuzoff, Irina
- Attems, Johannes
- Brayne, Carol
- Coyle-Gilchrist, Ian T S
- Chui, Helena C
- Fardo, David W
- Flanagan, Margaret E
- Halliday, Glenda
- Hokkanen, Suvi R K
- Hunter, Sally
- Jicha, Gregory A
- Katsumata, Yuriko
- Kawas, Claudia H
- Keene, C Dirk
- Kukull, Walter A
- Levey, Allan I
- Makkinejad, Nazanin
- Montine, Thomas J
- Murayama, Shigeo
- Murray, Melissa E
- Nag, Sukriti
- Rissman, Robert A
- Seeley, William W
- Sperling, Reisa A
- Yu, Lei
- Schneider, Julie A
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-30
- Volume
- 142
- Issue
- 6
- Pages
- 1503-1527
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6536849
- OpenAlex
- W2943828894
- Cited by
- 1,547
- References
- 276
- Citations by year
- 2026: 206 · 2025: 240 · 2024: 211 · 2023: 214 · 2022: 213 · 2021: 193 · 2020: 198 · 2019: 66
- FWCI
- 113.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by-nc)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- Apollo
- Funders
- NIA
- NACC
- NIH (U01 AG016976)
- National Health and Medical Research Council
- NHMRC (1132524, 1095127, 1037746)
- Senior Principal Research Fellowship (1079679)
- National Institutes of Health (P01 AG003949, R01 AG037491, P50 AG016574, R01 AG054449, P30 AG028303, P30 AG012300, P30 AG049638, P30 AG010124, P30 AG010161, P50 AG047366, P50 AG025688, P50 AG005131, R37 AG011378, R01 AG041851, R01 AG042210, R01 AG017917, R01 AG034374, UF1 AG053983, UF1 AG057707)
- NIHR (534906, NF-SI-0616–10090)
- National Institute for Health Research
- NHS
- Department of Health and Social Care
- Addenbrooke’s Charitable Trust
- Paul G. Allen Family Foundation and Alzheimer’s Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- limbic-predominant age-related TDP-43 encephalopathy, TDP-43 proteinopathy, hippocampal sclerosis, diagnostic criteria, neuropathological staging, amygdala, medial temporal lobe atrophy, genetic risk variants, gene regulatory networks, TMEM106B, ABCC9, apolipoprotein E, Alzheimer's disease, frontotemporal lobar degeneration
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Diseases, Female, Humans, Male, Middle Aged, Retrospective Studies, Frontotemporal Lobar Degeneration, TDP-43 Proteinopathies, Frontotemporal Dementia, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.